SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001140361-23-051318
Filing Date
2023-11-03
Accepted
2023-11-03 09:22:44
Documents
2
Period of Report
2023-11-01

Document Format Files

Seq Description Document Type Size
1 form3.html 3  
1 form3.xml 3 1458
2 EXHIBIT 24 ef20014010_ex24.htm EX-24 7970
  Complete submission text file 0001140361-23-051318.txt   11010
Mailing Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335
Business Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335 248-681-9815
Ocuphire Pharma, Inc. (Issuer) CIK: 0001228627 (see all company filings)

IRS No.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 37000 GRAND RIVER AVE SUITE 120 FARMINGTON HILLS MI 48335
Business Address
Magrath George (Reporting) CIK: 0001999390 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-34079 | Film No.: 231374683